Cutaneous Medicine and Immunotherapy Unit, St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine & NIHR Biomedical Research Centre at Guy's and St. Thomas's Hospitals and King's College London, London, UK; Division of Cancer Studies, Guy's Hospital, King's College, London, UK.
Clin Exp Allergy. 2013 Oct;43(10):1110-23. doi: 10.1111/cea.12178.
Several epidemiological studies have evaluated potential associations between allergy and risk of malignancy. It remains clear that the relationship between allergy and cancer is complex. Three hypotheses have been proposed to account for observed relationships: these are chronic inflammation, immunosurveillance, prophylaxis, and we propose adding a fourth: inappropriate T-helper 2 (Th2) immune skewing. Each of these attempts to explain either the increased or decreased risk of different cancer types in 'allergic' patients reported in the literature. All four hypotheses are based on known mechanisms of allergic inflammation and/or IgE antibody functions, and uphold the view of an immunological basis for the relationship between allergy and malignancies. This review summarizes and draws conclusions from the epidemiological literature examining the relationships between specific types of cancer and allergic diseases. Particular emphasis is placed on the most recent contributions to the field, and on consideration of the allergic immune mechanisms that may influence positive or negative associations.
几项流行病学研究评估了过敏与恶性肿瘤风险之间的潜在关联。目前仍然很清楚,过敏与癌症之间的关系很复杂。有三个假说可以解释观察到的关系:慢性炎症、免疫监视、预防,我们建议增加第四个假说:不当的辅助性 T 细胞 2(Th2)免疫偏倚。这些假说试图解释文献中报道的“过敏”患者中不同癌症类型的风险增加或降低。所有这四个假说都是基于过敏炎症和/或 IgE 抗体功能的已知机制,并支持过敏与恶性肿瘤之间存在免疫基础的观点。这篇综述总结了从流行病学文献中检查特定类型癌症与过敏性疾病之间关系的结论。特别强调了该领域的最新贡献,并考虑了可能影响阳性或阴性关联的过敏免疫机制。